Global RNA Drugs Market Research Report 2017

July 2017 | 112 pages | ID: G3ADA0E1794EN
QYResearch

Abstracts

In this report, the global RNA Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of RNA Drugs in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global RNA Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• siRNA
• ASO
• miRNA
• Nucleic Acid Aptamers

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of RNA Drugs for each application, including

• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global RNA Drugs Market Research Report 2017

1 RNA DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of RNA Drugs
1.2 RNA Drugs Segment by Type (Product Category)
  1.2.1 Global RNA Drugs Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
  1.2.2 Global RNA Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 siRNA
  1.2.4 ASO
  1.2.5 miRNA
  1.2.6 Nucleic Acid Aptamers
1.3 Global RNA Drugs Segment by Application
  1.3.1 RNA Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 Global RNA Drugs Market by Region (2012-2022)
  1.4.1 Global RNA Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of RNA Drugs (2012-2022)
  1.5.1 Global RNA Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global RNA Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL RNA DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global RNA Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global RNA Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global RNA Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global RNA Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global RNA Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers RNA Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 RNA Drugs Market Competitive Situation and Trends
  2.5.1 RNA Drugs Market Concentration Rate
  2.5.2 RNA Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL RNA DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global RNA Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global RNA Drugs Production and Market Share by Region (2012-2017)
3.3 Global RNA Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL RNA DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global RNA Drugs Consumption by Region (2012-2017)
4.2 North America RNA Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe RNA Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China RNA Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan RNA Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia RNA Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India RNA Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL RNA DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global RNA Drugs Production and Market Share by Type (2012-2017)
5.2 Global RNA Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global RNA Drugs Price by Type (2012-2017)
5.4 Global RNA Drugs Production Growth by Type (2012-2017)

6 GLOBAL RNA DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global RNA Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global RNA Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL RNA DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 RNA Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Pfizer RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 RNA Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Roche RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Sanofi-Aventis
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 RNA Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Sanofi-Aventis RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 RNA Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Abbott Laboratories RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Arrowhead Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 RNA Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Arrowhead Pharmaceuticals RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Benitec Biopharma
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 RNA Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Benitec Biopharma RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Calimmune Inc
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 RNA Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Calimmune Inc RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Dicerna
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 RNA Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Dicerna RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Gradalis
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 RNA Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Gradalis RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Quark
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 RNA Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Quark RNA Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 RXi
7.12 Senesco
7.13 Silence Therapeutics
7.14 Silenseed
7.15 Tekmira
7.16 Alnylam Pharmaceuticals

8 RNA DRUGS MANUFACTURING COST ANALYSIS

8.1 RNA Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of RNA Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 RNA Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of RNA Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL RNA DRUGS MARKET FORECAST (2017-2022)

12.1 Global RNA Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global RNA Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global RNA Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global RNA Drugs Price and Trend Forecast (2017-2022)
12.2 Global RNA Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America RNA Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe RNA Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China RNA Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan RNA Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia RNA Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India RNA Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global RNA Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global RNA Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of RNA Drugs
Figure Global RNA Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global RNA Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of siRNA
Table Major Manufacturers of siRNA
Figure Product Picture of ASO
Table Major Manufacturers of ASO
Figure Product Picture of miRNA
Table Major Manufacturers of miRNA
Figure Product Picture of Nucleic Acid Aptamers
Table Major Manufacturers of Nucleic Acid Aptamers
Figure Global RNA Drugs Consumption (K Units) by Applications (2012-2022)
Figure Global RNA Drugs Consumption Market Share by Applications in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global RNA Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global RNA Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global RNA Drugs Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global RNA Drugs Major Players Product Capacity (K Units) (2012-2017)
Table Global RNA Drugs Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global RNA Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global RNA Drugs Capacity (K Units) of Key Manufacturers in 2016
Figure Global RNA Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global RNA Drugs Major Players Product Production (K Units) (2012-2017)
Table Global RNA Drugs Production (K Units) of Key Manufacturers (2012-2017)
Table Global RNA Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 RNA Drugs Production Share by Manufacturers
Figure 2017 RNA Drugs Production Share by Manufacturers
Figure Global RNA Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global RNA Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global RNA Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global RNA Drugs Revenue Share by Manufacturers
Table 2017 Global RNA Drugs Revenue Share by Manufacturers
Table Global Market RNA Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market RNA Drugs Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers RNA Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers RNA Drugs Product Category
Figure RNA Drugs Market Share of Top 3 Manufacturers
Figure RNA Drugs Market Share of Top 5 Manufacturers
Table Global RNA Drugs Capacity (K Units) by Region (2012-2017)
Figure Global RNA Drugs Capacity Market Share by Region (2012-2017)
Figure Global RNA Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global RNA Drugs Capacity Market Share by Region
Table Global RNA Drugs Production by Region (2012-2017)
Figure Global RNA Drugs Production (K Units) by Region (2012-2017)
Figure Global RNA Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global RNA Drugs Production Market Share by Region
Table Global RNA Drugs Revenue (Million USD) by Region (2012-2017)
Table Global RNA Drugs Revenue Market Share by Region (2012-2017)
Figure Global RNA Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global RNA Drugs Revenue Market Share by Region
Figure Global RNA Drugs Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global RNA Drugs Consumption (K Units) Market by Region (2012-2017)
Table Global RNA Drugs Consumption Market Share by Region (2012-2017)
Figure Global RNA Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global RNA Drugs Consumption (K Units) Market Share by Region
Table North America RNA Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe RNA Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table China RNA Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan RNA Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia RNA Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table India RNA Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global RNA Drugs Production (K Units) by Type (2012-2017)
Table Global RNA Drugs Production Share by Type (2012-2017)
Figure Production Market Share of RNA Drugs by Type (2012-2017)
Figure 2016 Production Market Share of RNA Drugs by Type
Table Global RNA Drugs Revenue (Million USD) by Type (2012-2017)
Table Global RNA Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of RNA Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of RNA Drugs by Type
Table Global RNA Drugs Price (USD/Unit) by Type (2012-2017)
Figure Global RNA Drugs Production Growth by Type (2012-2017)
Table Global RNA Drugs Consumption (K Units) by Application (2012-2017)
Table Global RNA Drugs Consumption Market Share by Application (2012-2017)
Figure Global RNA Drugs Consumption Market Share by Applications (2012-2017)
Figure Global RNA Drugs Consumption Market Share by Application in 2016
Table Global RNA Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global RNA Drugs Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA Drugs Production Growth Rate (2012-2017)
Figure Pfizer RNA Drugs Production Market Share (2012-2017)
Figure Pfizer RNA Drugs Revenue Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA Drugs Production Growth Rate (2012-2017)
Figure Roche RNA Drugs Production Market Share (2012-2017)
Figure Roche RNA Drugs Revenue Market Share (2012-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA Drugs Production Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA Drugs Production Market Share (2012-2017)
Figure Sanofi-Aventis RNA Drugs Revenue Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA Drugs Production Growth Rate (2012-2017)
Figure Abbott Laboratories RNA Drugs Production Market Share (2012-2017)
Figure Abbott Laboratories RNA Drugs Revenue Market Share (2012-2017)
Table Arrowhead Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead Pharmaceuticals RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Production Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Production Market Share (2012-2017)
Figure Arrowhead Pharmaceuticals RNA Drugs Revenue Market Share (2012-2017)
Table Benitec Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Benitec Biopharma RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA Drugs Production Growth Rate (2012-2017)
Figure Benitec Biopharma RNA Drugs Production Market Share (2012-2017)
Figure Benitec Biopharma RNA Drugs Revenue Market Share (2012-2017)
Table Calimmune Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Calimmune Inc RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA Drugs Production Growth Rate (2012-2017)
Figure Calimmune Inc RNA Drugs Production Market Share (2012-2017)
Figure Calimmune Inc RNA Drugs Revenue Market Share (2012-2017)
Table Dicerna Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA Drugs Production Growth Rate (2012-2017)
Figure Dicerna RNA Drugs Production Market Share (2012-2017)
Figure Dicerna RNA Drugs Revenue Market Share (2012-2017)
Table Gradalis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gradalis RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA Drugs Production Growth Rate (2012-2017)
Figure Gradalis RNA Drugs Production Market Share (2012-2017)
Figure Gradalis RNA Drugs Revenue Market Share (2012-2017)
Table Quark Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark RNA Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA Drugs Production Growth Rate (2012-2017)
Figure Quark RNA Drugs Production Market Share (2012-2017)
Figure Quark RNA Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Drugs
Figure Manufacturing Process Analysis of RNA Drugs
Figure RNA Drugs Industrial Chain Analysis
Table Raw Materials Sources of RNA Drugs Major Manufacturers in 2016
Table Major Buyers of RNA Drugs
Table Distributors/Traders List
Figure Global RNA Drugs Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global RNA Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global RNA Drugs Production (K Units) Forecast by Region (2017-2022)
Figure Global RNA Drugs Production Market Share Forecast by Region (2017-2022)
Table Global RNA Drugs Consumption (K Units) Forecast by Region (2017-2022)
Figure Global RNA Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America RNA Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America RNA Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe RNA Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe RNA Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China RNA Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China RNA Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan RNA Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan RNA Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia RNA Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia RNA Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India RNA Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India RNA Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India RNA Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global RNA Drugs Production (K Units) Forecast by Type (2017-2022)
Figure Global RNA Drugs Production (K Units) Forecast by Type (2017-2022)
Table Global RNA Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global RNA Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global RNA Drugs Price Forecast by Type (2017-2022)
Table Global RNA Drugs Consumption (K Units) Forecast by Application (2017-2022)
Figure Global RNA Drugs Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source